InsiderSignal.AI

InsiderSignal.ai

EW - Edwards Lifesciences Corp

Insider Sale by Lippis Daniel J. (CVP, TAVR)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Lippis Daniel J., serving as CVP, TAVR at Edwards Lifesciences Corp (EW), sold 1,019 shares at $85.38 per share, for a total transaction value of $87,004.00. Following this transaction, Lippis Daniel J. now holds 33,934 shares of EW.

This sale represents a 3.00% decrease in Lippis Daniel J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, meaning the disclosure happened on the same day as the trade.

Edwards Lifesciences Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lippis Daniel J.

CVP, TAVR

Daniel J. Lippis is a Corporate Vice President at Edwards Lifesciences Corporation (NYSE: EW), currently serving as CVP, TAVR (Transcatheter Aortic Valve Replacement), a role that involves leading the TAVR portfolio and general management of this critical business unit.[[1]](https://www.gurufocus.com/insider/263875/daniel-j.-lippis)[[2]](https://www.ainvest.com/news/edwards-lifesciences-cvp-daniel-lippis-buys-sells-shares-59-26-85-7-share-2601/)[[4]](https://fintool.com/app/research/companies/EW/people/daniel-lippis)[[8]](https://www.edwards.com/about-us/our-leaders) Aged 49, he joined Edwards Lifesciences as an executive in 2010 and has held progressive leadership positions, including Corporate Vice President and General Manager of the Transcatheter Aortic Valve business, as well as Corporate Vice President for Japan, Greater China, and Asia Pacific (JAPAC) starting in January 2024.[[4]](https://fintool.com/app/research/companies/EW/people/daniel-lippis)[[7]](https://www.comparably.com/companies/edwards-lifesciences-corporation/daniel-j-lippis)[[8]](https://www.edwards.com/about-us/our-leaders) Lippis owns approximately 22,002 shares of EW stock, valued at over $2 million, and has been active in insider trading, including buying 1,019 shares at $59.26 and selling them at $85.70 on January 9, 2026, along with prior transactions such as selling shares in November 2025 and April 2025.[[1]](https://www.gurufocus.com/insider/263875/daniel-j.-lippis)[[2]](https://www.ainvest.com/news/edwards-lifesciences-cvp-daniel-lippis-buys-sells-shares-59-26-85-7-share-2601/)[[5]](https://www.tradingview.com/news/tradingview:d0c650fbcd565:0-executives-at-edwards-lifesciences-corp-execute-stock-sales/)[[6]](https://www.investing.com/news/insider-trading-news/edwards-lifesciences-cvp-daniel-lippis-sells-21183-in-stock-93CH-3975284) With more than 25 years of experience in sales, marketing, and leadership in the medical device industry, he plays a key role in advancing Edwards Lifesciences' structural heart innovations.[[7]](https://www.comparably.com/companies/edwards-lifesciences-corporation/daniel-j-lippis)

View full insider profile →

Trade Price

$85.38

Quantity

1,019

Total Value

$87,004.00

Shares Owned

33,934

Trade Date

Wednesday, March 11, 2026

4 days ago

SEC Filing Date

Wednesday, March 11, 2026

HEALTHCAREMEDICAL DEVICES

About Edwards Lifesciences Corp

Company Overview

No company information available
View news mentioning EW

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4696255

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime